Background: We conducted this study to investigate whether norepinephrine increases cardiac contractility when administered during the early phase of septic shock. Methods: We studied 38 patients with septic shock who had been resuscitated for <3 h and whose mean arterial pressure (MAP) remained <65 mm Hg. Echocardiographic variables were obtained before (T 0 ) and after either initiation or an increase in the dose of a norepinephrine infusion to increase MAP to ! 65 mm Hg (T 1 ). We collected left ventricular ejection fraction (LVEF), velocity-time integral of the left ventricular outflow tract (VTI), tissue Doppler imaging of mean systolic velocity of the lateral tricuspid annulus (S a ) and of the lateral mitral annulus (S m ), and tricuspid annular plane systolic excursion (TAPSE). Results: There were significant (P<0.05) increases from T 0 to T 1 in MAP [mean (SD): from 56 (7) 
in left ventricular afterload, 1 especially when cardiac function is already impaired. Nevertheless, by restoring arterial tone NE may restore diastolic arterial pressure (DAP), hence the coronary perfusion of the left ventricle. 2 This might reduce some degree of the ischaemic myocardial dysfunction that can occur in patients with prior coronary artery disease and low DAP. In addition, NE may exert a positive effect on cardiac contractility through b 1 -adrenergic stimulation. 3 Although sepsis-induced downregulation of b 1 -adrenergic receptors may occur, 4 5 it may be relatively late, 6 and thus, not observed when NE is administered early. However, the effects of early administration of NE on cardiac systolic function in human septic shock have not been studied specifically. The aim of this study, therefore, was to test the hypothesis that early administration of NE in septic shock patients with severe hypotension might enhance left ventricular systolic function.
Methods
This prospective observational study was performed between October 2014 and January 2016 in two 15-bed intensive care units. The study was approved by the institutional review board of our institution (Comit e de Protection des Personnes, Paris-Ile-de-France VII). Informed patient (or next-of-kin) consent was obtained from all patients. Our study was registered in ClinicalTrials.gov (NCT02750683).
We included adult patients with septic shock who had a mean arterial pressure (MAP) <65 mm Hg (measured by an intra-arterial catheter) within the first 3 h after the start of resuscitation. In the two units, no fixed predefined fluid management protocol is used. Instead, fluid management is personalized and decided by the physician in charge and in consideration of the patient's past medical history, clinical signs, and dynamic indices of fluid responsiveness when available or results of a fluid challenge, according to the current European recommendations. 7 For every patient, early initiation of NE was decided by the physician in charge on the basis of lifethreatening hypotension even if hypovolaemia had not been totally resolved, as recommended. 8 Before starting the study, patients could have received NE already, but the desired target value of MAP had not yet been achieved. For every patient included (time T 0 ), NE was either initiated or its dose increased in order to achieve the desired MAP target value (!65 mm Hg, or more in the event of a history of chronic hypertension). Time T1 was defined as the time when the desired MAP target was achieved. If a change of the associated therapy (fluid administration, ventilator settings, and other drugs) was decided by the attending physician, the patient was not included.
Data collection
Clinical information, the volume of fluids administered before inclusion, use of mechanical ventilation, the time interval between the start of resuscitation and T 0 , and the time interval between T 0 and T 1 were noted.
Haemodynamic data
At T 0 and at T 1 , we recorded heart rate (HR), systolic arterial pressure (SAP), DAP, MAP, and the blood lactate concentration.
Transthoracic echocardiographic data
Transthoracic echocardiographic (TTE) examination was performed at T 0 and T 1 with a 3.75 MHz probe using a CX50 Philips (Philips Healthcare, DA Best, Holland) and a Vivid i (GE Healthcare, Freiburg, Germany) machine. There was one echocardiographic operator in each intensive care unit, both of them (O.H., M.J.) physicians with a national echocardiographic diploma and !3yr training.
Patients were in supine flat or lateral supine positions depending on their respiratory tolerance. Two-, four-, and fivechamber apical views were used in order to determine the left ventricular ejection fraction (LVEF), calculated by the biplane method of disc summation (modified Simpson's rule), and the following other indices of right or left ventricular systolic function: tissue Doppler imaging of mean systolic velocity of the lateral tricuspid annulus (S a ), tricuspid annular plane systolic excursion (TAPSE) measured by M-mode echocardiography, and tissue Doppler imaging of mean systolic velocity of the lateral mitral annulus (S m ). We also collected the velocity-time integral of the flow in the left ventricular outflow tract (VTI), and we calculated cardiac output (CO) by multiplying the heart rate by the stroke volume. The latter was calculated as the product of VTI by the area of the left ventricular outflow tract. We also collected the left ventricular end-diastolic area (LVEDA) from the four-chamber apical view, the peak early (E) and late (A) transmitral flow velocity, tissue Doppler imaging of the mean early diastolic velocity (E') of the lateral mitral annulus, and the ratios E/A and E/E'. All the variables were averaged over three beats, or over five beats in the event of atrial fibrillation.
We also calculated an estimate of the effective arterial elastance (E a ). The E a is generally calculated using the following formula: 0.9 Â aortic end-systolic pressure/stroke volume. 9 As we inserted the arterial catheter in the femoral artery, and given the low pulse wave amplification phenomenon between the aorta and the location of catheter's tip (normally close to the iliac artery), we made the reasonable assumption that the SAP approximated the aortic end-systolic pressure, so that the estimated E a was calculated as 0. 
Statistical analysis
In order to calculate the number of patients needed for our study, we estimated from the previous literature 11 that an increase of 5% in LVEF from T 0 to T 1 was clinically relevant, and taking into account an a-risk of 5% and a b-risk of 20%, at least 34 patients needed to be included. The distribution of the data was evaluated using the Kolmogorov-Smirnov test. Data are expressed as the mean (SD) or as the median [interquartile range], as appropriate. Paired comparisons for numerical variables were performed using Student's paired t-test except for variables with a non-normal distribution (Wilcoxon test). The intra-observer and the interobserver reproducibility was assessed in 10 randomly selected patients for LVEF, VTI, E, A, E', S m , S a , LVEDA, and TAPSE. Each variable was obtained twice by the same observer and the coefficient of variation calculated. The statistical analysis was performed with MedCalc 8.1.0.0 (Mariakerke, Belgium). A Pvalue <0.05 was considered statistically significant.
Results
All data except the dose of NE, the volume of fluids received before inclusion, and the time intervals between the start of resuscitation and T 0 and between T 0 and T 1 were normally distributed.
Patient characteristics
Thirty-eight patients with septic shock (24 males, 14 females) were included. The mean age [range] was 68 [30À91] yr; mean simplified acute physiology score (SAPS2) score at admission was 55 (20) . The main patients' characteristics at T 0 are displayed in Table 1 (Table 1) , and the mortality rate at discharge from the intensive care unit was 38%, and at day 28 it was 39%.
Haemodynamic variables
In the whole group, all the components of arterial blood pressure increased significantly between T 0 and T 1 , whereas blood lactate significantly decreased (Table 2) .
Echocardiographic variables
For the LVEF, VTI, Sm, Sa, E, E ' , A, LVEDA and TAPSE, the intraobserver reproducibility defined as the coefficient of variation was 3.2 (3.1%), 6.6 (4.6%), 5. (Table 3 and Fig. 1 ). The LVEDA and the E/A and E/E ' ratios did not change.
In the subgroup of patients (n¼15) with baseline LVEF <45%, from T 0 to T 1 , VTI increased from 16 (6) to 18 (7) cm (P<0.05) and LVEF from 36 (7) to 44 (10%) (P<0.05), but S m , TAPSE, and S a did not change significantly (Table 4 and Fig. 2 ).
Finally, from T 0 to T 1 , the estimated E a increased significantly from 1.30 (0.45) to 1.75 (0.72) mm Hg ml e1 and the estimated E es increased significantly from 1.31 (0.61) to 2.31 (1.03) mm Hg ml À1 .
Discussion
In this study, we found that the early use of NE in patients with septic shock to target MAP values of !65 mm Hg improves left and right ventricle systolic function variables, increases cardiac output, and decreases blood lactate without increasing HR. The increase in LVEF and in VTI remained in the subgroup of patients with left ventricular dysfunction. To our knowledge, no previous clinical study has reported the cardiac effects of NE during the early phase of resuscitation of septic shock using TTE. This non-invasive method, which provides a detailed characterization of cardiac function, 12 is recommended to be performed as soon as possible in shock states. 7 13 In the absence of an increase in cardiac contractility, LVEF should have decreased with NE from T 0 to T 1 , because the left ventricular afterload, which is another important determinant of LVEF, probably increased with NE, as indicated by the marked increase in SAP and also suggested by the increase in the estimated E a . Thus, the significant increase in LVEF with NE, in spite of the increased left ventricular afterload, strongly suggests that NE increased the left ventricular contractility. This is also suggested by the increase in the estimated E es , although this calculated variable suffers from limitations (see below).
Norepinephrine has a-and b 1 -adrenergic properties, 3 which may enhance cardiac contractility through two main mechanisms: (i) an indirect effect through the improvement of coronary perfusion via the increase in DAP (a-adrenergic (6) mm Hg] at T 0 that may have resulted in a decreased coronary perfusion. It can therefore be speculated that restoration of DAP might have contributed to restore the coronary perfusion and to improve the cardiac performance in some of our patients. Any invasive measurements of lactate concentration in the coronary sinus to assess the effect of NE on coronary perfusion more precisely were obviously unfeasible in this group of patients who primarily needed resuscitation for severe shock and life-threatening hypotension.
Secondly, NE has the potential to increase cardiac contractility owing to its b 1 -adrenergic receptor stimulation. 3 Nevertheless, during sepsis, b 1 -adrenergic stimulation of cyclic adenosine monophosphate may be impaired, with a resulting effect of myocardial hyporesponsiveness to catecholamines. 4 5 In this regard, dobutamine (a b 1 -adrenergic agent) was shown not to increase the left ventricular endsystolic elastance in human septic shock. 14 However, in experimental sepsis, a biphasic change (an increase, then a decrease) in the density of b 1 -adrenergic receptors, owing to a phenomenon called receptor internalization, was reported. 15 Similar results were found by Abi-Gerges and colleagues, 6 who reported time-dependent changes in the adenylcyclase pathway in cardiac myocytes, with an initial phase of early potentiation of the b 1 -adrenergic response ('upregulation'), followed by a downregulation phase. 6 In our study, the mean time interval between the start of resuscitation and T 0 was short enough to account for a positive effect of NE on cardiac systolic function indices through b 1 -adrenergic stimulation.
In our study, the mean value of LVEF at T 0 was 49%, which is quite low in such a situation of low SAP, hence of low left ventricular afterload. This suggests some impairment of left ventricular contractility. In 15 out of the 38 patients (39%), LVEF was <45%, a result that is in perfect agreement with that reported by Vieillard-Baron and colleagues, 1 who found that 40% of patients with septic shock during the first day had an LVEF <45%. Importantly, the positive effect of NE on left ventricular function remained in this subgroup of 15 patients with low LVEF, in spite of the increase in SAP. This contradicts the idea that NE exerts a deleterious effect on left ventricular function because of its increasing effect on left ventricular afterload. Our results are in agreement with those of an experimental study of septic myocardial depression in rats. In that study, NE was shown to be as effective as epinephrine (at equipressor doses) to improve LVEF and cardiac contractility (assessed using a conductance catheter), whereas phenylephrine, a pure a-adrenergic agent, did not exert such effects. 16 We measured LVEF to assess the cardiac systolic effects of NE because it is the most widely used echocardiographic variable to assess left ventricular systolic function. 17 We also measured S m , S a , and TAPSE, which have been introduced more recently to assess the left and right ventricular systolic function. 18À20 Although we used different techniques (tissue Doppler imaging, time-motion etc.), all the markers of the cardiac systolic function increased in our population, reinforcing our conclusion of increased cardiac systolic function with early administration of NE.
Several limitations of our study should be acknowledged. This was a prospective but observational study, and the clinical management of patients was done exclusively by the physicians in charge. In this regard, the MAP reached at T 1 was 80 (9) mm Hg, that is, within a wide range of values >65 mm Hg, which is probably attributable to the fact that the MAP target was adjusted in consideration of several factors, Table 3 Echocardiographic variables before (T 0 ) and after (T 1 ) initiation of norepinephrine (or increase in its dose) for the whole population (n¼38). CO, cardiac output; peak early (E) and late (A) transmitral flow velocity; E', tissue Doppler imaging of the mean early diastolic velocity of the lateral mitral annulus; LVEDA, left ventricular end-diastolic area; LVEF, left ventricular ejection fraction; S a , tissue Doppler imaging of mean systolic velocity of the lateral tricuspid annulus; S m , tissue Doppler imaging of mean systolic velocity of the lateral mitral annulus; TAPSE, tricuspid annular plane systolic excursion; VTI, velocity-time integral of the flow in the left ventricular outflow tract including a history of chronic hypertension (55% of our patients), individual clinical responses, and the presence of other cardiovascular risk factors suggestive of atherosclerosis. 21 In spite of the presence of early left ventricular dysfunction in some patients, the physicians in charge did not administer dobutamine, considering that it was urgent first to correct the severe hypotension with NE, as is recommended in septic shock 8 and in cardiogenic shock 22 states. Obviously, our study cannot suggest that NE is superior to dobutamine to treat early sepsis-induced myocardial depression because we did not compare NE with dobutamine. It is possible that dobutamine at this stage would also have increased cardiac systolic function indices, because dobutamine is considered a more powerful b 1 -adrenergic agent than NE in sepsis. 23 It should be stressed, however, that unlike NE, dobutamine has the potential to decrease DAP, and eventually, the coronary perfusion pressure owing to its vascular b 2 -adrenergic properties.
We previously showed that NE increases cardiac preload and cardiac output and decreases cardiac preload dependence. 24 25 Such cardiac preload effects are assumed to be related in part to the a-adrenergically mediated decrease in systemic venous capacitance. 26 27 Our patients were included in the early phase of septic shock, even when hypovolaemia was not totally resolved, as recommended in the event of life- threatening hypotension by the Surviving Sepsis Campaign guidelines published at the time of the patients' inclusion in the study. 8 Therefore, in spite of prior fluid administration (median value of 1500 ml), we cannot exclude some degree of preload dependence in our patients, hence an additional preload effect of NE on VTI. Obviously, such an effect cannot fully account for the increase in LVEF, which essentially depends on left ventricular afterload and contractility, and only a little on left ventricular preload. 10 Moreover, the latter effect could be significant only in the event of very low cardiac preload. 10 Even if we did not precisely assess cardiac preload in our study, the absence of a significant (P¼0.12) increase in LVEDA from T 0 to T 1 is not in favour of a preload effect of NE. However, we cannot exclude the possibility that including a larger number of patients would have resulted in a significant increase in LVEDA. Furthermore, the E/E' ratio, which is assumed to estimate the left ventricular filling pressure, 28 was in the normal range at baseline and did not increase with NE. However, E/E ' is not a very accurate estimate of left ventricular filling pressure when it is between 8 and 15, 29 as it was for most of our patients. We thus cannot totally exclude the possibility that NE had increased left ventricular preload, hence VTI, in preloaddependent patients. Nevertheless, such an effect was unlikely to have occurred in patients with low LVEF, who are supposed to be preload -independent. We could not provide a precise estimation of E es from echocardiographic measurements using the method of Chen and colleagues 30 recently applied to patients with septic shock by Guarracino and colleagues. 31 We only provided an estimation of E es from the application of a formula previously proposed by Robotham and colleagues, 10 a formula that suffers from limitations. Among these limitations is the way to calculate E a , which is included in the estimated E es formula. For calculation of E a , we approximated the aortic end-systolic pressure by the SAP. Such an approximation is reasonable because we measured SAP at the tip of an arterial catheter inserted in the femoral artery and thus at a location close to the aorta. Even if we could not accurately assess the left ventricular contractility, it is hard to believe that NE did not increase the left ventricular contractility because not only the estimated E es increased but also, more simply, the LVEF increased despite the increase in arterial blood pressure, and presumably, in left ventricular afterload. We did not evaluate the long-term effects of NE on cardiac function. Thus, we cannot be sure that the beneficial cardiac effects of NE observed when the desired MAP target was achieved would persist over time. Finally, the subgroup of patients with low LVEF (<45%) at T 0 is small, but the results found in this subgroup are nevertheless worth reporting, although they need to be confirmed in larger groups of patients.
In conclusion, NE administration during early resuscitation of patients with severe septic shock increased echocardiographic indices of cardiac systolic function despite the presumable increase in left ventricular afterload secondary to the increase in arterial pressure. These findings suggest that NE increased cardiac contractility during the early phase of resuscitation of human septic shock. Whether such a beneficial effect persists over time remains to be evaluated. 
